المؤلفون: Rafal Dziadziuszko, Nir Peled, Tony Mok, Solange Peters, Santiago Ponce Aix, Jorge Alatorre-Alexander, Brian D. Vicuna, Margaret Maclennan, Vijay Bhagawati-Prasad, Sarah M. Shagan, Erica Schleifman, Thorsten Ruf, Michael S. Mathisen, Shirish M. Gadgeel

المصدر: Contemporary Oncology, Vol 27, Iss 4, Pp 217-223 (2024)

مصطلحات موضوعية: alectinib, blood-based assay, blood first assay screening trial (bfast), non small cell lung cancer, nsclc, ret fusion, ctdna, circulating tumour dna, liquid biopsy, ngs, Medicine

وصف الملف: electronic resource

Relation: https://www.termedia.pl/High-dose-alectinib-for-RET-fusion-positive-non-small-cell-lung-cancer-in-the-Blood-First-Assay-Screening-Trial,3,52369,1,1.html; https://doaj.org/toc/1428-2526; https://doaj.org/toc/1897-4309

URL الوصول: https://doaj.org/article/de66fd03358a49bbbdeaeff487884027

المؤلفون: Michael S. Mathisen, Hagop M. Kantarjian, Jorge Cortes, Elias Jabbour

المصدر: Haematologica, Vol 96, Iss 3 (2011)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://haematologica.org/article/view/5893; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721

URL الوصول: https://doaj.org/article/d3599aba03664d3fba619f054c1f65b1

المؤلفون: Solange Peters, Rafal Dziadziuszko, Alessandro Morabito, Enriqueta Felip, Shirish M. Gadgeel, Parneet Cheema, Manuel Cobo, Zoran Andric, Carlos H. Barrios, Masafumi Yamaguchi, Eric Dansin, Pongwut Danchaivijitr, Melissa Johnson, Silvia Novello, Michael S. Mathisen, Sarah M. Shagan, Erica Schleifman, Jin Wang, Mark Yan, Simonetta Mocci, David Voong, David A. Fabrizio, David S. Shames, Todd Riehl, David R. Gandara, Tony Mok

المساهمون: Institut Català de la Salut, [Peters S] Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland. [Dziadziuszko R] Medical University of Gdańsk, Gdańsk, Poland. [Morabito A] Istituto Nazionale Tumori ‘Fondazione G Pascale’, IRCCS, Naples, Italy. [Felip E] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Gadgeel SM] Henry Ford Cancer Institute/Henry Ford Health System, Detroit, MI, USA. [Cheema P] William Osler Health System, University of Toronto, Brampton, Ontario, Canada, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Lung Neoplasms, phase 3 trial, Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Marcadors tumorals, terapéutica::terapia biológica::inmunomodulación::inmunoterapia [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], blood-based tumor, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], factores biológicos::biomarcadores::marcadores tumorales [COMPUESTOS QUÍMICOS Y DROGAS], Atezolizumab versus chemotherapy, NSCLC, blood-based tumor, mutational burden, phase 3 trial, General Medicine, Pulmons - Càncer - Immunoteràpia, Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [DISEASES], neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas [ENFERMEDADES], NSCLC, Antibodies, Monoclonal, Humanized, Other subheadings::Other subheadings::/drug therapy [Other subheadings], General Biochemistry, Genetics and Molecular Biology, Atezolizumab versus chemotherapy, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, Immunotherapy, Biological Factors::Biomarkers::Biomarkers, Tumor [CHEMICALS AND DRUGS], mutational burden

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::350ee20c9b5fb25ff060121a7b7b6043
https://hdl.handle.net/11351/9339

المؤلفون: Michael S. Mathisen, Jagpreet Chhatwal, Hagop M. Kantarjian

المصدر: Cancer. 121:3372-3379

مصطلحات موضوعية: Oncology, Drug, Cancer Research, medicine.medical_specialty, business.industry, media_common.quotation_subject, Treatment outcome, Drug prices, Cancer, medicine.disease, Food and drug administration, Internal medicine, medicine, Rituximab, business, Intensive care medicine, health care economics and organizations, media_common, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bc796842c4a96f7bb8b64fa01d5256c0
https://doi.org/10.1002/cncr.29512

المؤلفون: Dimitrios Farmakiotis, Emily Wang, Deborah McCue, Hagop M. Kantarjian, Dimitrios P. Kontoyiannis, Daisy Yang, Michael S. Mathisen

المصدر: Journal of Antimicrobial Chemotherapy. 70:2362-2368

مصطلحات موضوعية: Adult, Male, Microbiology (medical), medicine.medical_specialty, Echinocandin, Population, Microbial Sensitivity Tests, Candida parapsilosis, Candida tropicalis, Echinocandins, Lipopeptides, Young Adult, chemistry.chemical_compound, Caspofungin, Drug Resistance, Multiple, Fungal, Internal medicine, medicine, Humans, Pharmacology (medical), education, Aged, Candida, Retrospective Studies, Original Research, Pharmacology, education.field_of_study, Leukemia, biology, Candida glabrata, Candidemia, Middle Aged, Caspofungin Acetate, biology.organism_classification, Survival Analysis, Infectious Diseases, chemistry, Immunology, Female, Fluconazole, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd760ed4c850d0040bb1765064ae7ab4
https://doi.org/10.1093/jac/dkv087

المؤلفون: Hady Ghanem, Farhad Ravandi, Issa F. Khouri, Uday R. Popat, Guillermo Garcia-Manero, Elias Jabbour, Betul Oran, Richard E. Champlin, Marylou Cardenas Turanzas, Naval Daver, Hagop M. Kantarjian, Jorge E. Cortes, A. Megan Cornelison, Marcos de Lima, Sergio Giralt, Stefan O. Ciurea, Michael S. Mathisen

المصدر: American Journal of Hematology. 89:395-398

مصطلحات موضوعية: Chemotherapy, medicine.medical_specialty, business.industry, medicine.medical_treatment, Salvage therapy, Induction chemotherapy, Hematology, Hematopoietic stem cell transplantation, medicine.disease, Surgery, Transplantation, Leukemia, Median follow-up, Cytarabine, Medicine, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2389bacc8e4a0564d76e84177c6fa045
https://doi.org/10.1002/ajh.23655

المؤلفون: Elias Jabbour, Michael S. Mathisen, Farhad Ravandi, Hagop M. Kantarjian, Jorge E. Cortes

المصدر: Clinical Investigation. 3:979-990

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Chemotherapy, Anthracycline, business.industry, medicine.drug_class, Gemtuzumab ozogamicin, medicine.medical_treatment, General Medicine, Disease, Monoclonal antibody, Targeted therapy, Clinical trial, Internal medicine, Immunology, medicine, Cytarabine, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::00aff14ebcbccba132d4e8079914a050
https://doi.org/10.4155/cli.13.78

المؤلفون: Naveen Pemmaraju, Zeev Estrov, Maro Ohanian, Jorge E. Cortes, Michael S. Mathisen, Alfonso Quintás-Cardama, Gautam Borthakur

المصدر: Clinical Lymphoma Myeloma and Leukemia. 13:93-96

مصطلحات موضوعية: Cancer Research, Pathology, medicine.medical_specialty, Myeloid, business.industry, Myeloid leukemia, Hematology, medicine.disease, Article, Leukemia, Myeloid, Acute, Leukemia, medicine.anatomical_structure, Oncology, hemic and lymphatic diseases, Acute myelomonocytic leukemia, medicine, Humans, Female, Sarcoma, Choroid, Sarcoma, Myeloid, Complication, business, Aged

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c87410e4447331d6c2f7c6fdf74de441
https://doi.org/10.1016/j.clml.2012.07.008

المؤلفون: Susan O'Brien, Elias Jabbour, Michael S. Mathisen

المصدر: Journal of the National Comprehensive Cancer Network. 10:1049-1053

مصطلحات موضوعية: Proto-Oncogene Proteins c-bcr, Dasatinib, Fusion Proteins, bcr-abl, Antineoplastic Agents, Piperazines, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Protein-Tyrosine Kinases, medicine, Humans, Proto-Oncogene Proteins c-abl, Protein Kinase Inhibitors, business.industry, medicine.disease, Thiazoles, Pyrimidines, Imatinib mesylate, Oncology, Benzamides, Imatinib Mesylate, Cancer research, business, Chronic myelogenous leukemia, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd919072185af61edd3e39220a540313
https://doi.org/10.6004/jnccn.2012.0110

المؤلفون: Susan O'Brien, Hagop M. Kantarjian, Jorge E. Cortes, Farhad Ravandi, Michael S. Mathisen, Deborah A. Thomas

المصدر: Current Hematologic Malignancy Reports. 6:187-194

مصطلحات موضوعية: Cancer Research, medicine.medical_treatment, Dasatinib, Fusion Proteins, bcr-abl, Philadelphia chromosome, Piperazines, Article, hemic and lymphatic diseases, medicine, Humans, Transplantation, Homologous, Philadelphia Chromosome, Protein Kinase Inhibitors, Clinical Trials as Topic, Chemotherapy, Philadelphia Chromosome Positive, business.industry, Imatinib, Hematology, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Protein-Tyrosine Kinases, medicine.disease, Combined Modality Therapy, Transplantation, Thiazoles, Pyrimidines, Imatinib mesylate, Oncology, Benzamides, Imatinib Mesylate, Cancer research, business, Tyrosine kinase, Stem Cell Transplantation, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e09599b4172f589cae67488a55b872
https://doi.org/10.1007/s11899-011-0093-y